首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

MEDICINAL RESEARCH REVIEWS
ISSN：0198-6325

MEDICINAL RESEARCH REVIEWS

MED RES REV
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约稿?周期不定
新锐分区：医学1区
年发文量：68
影响因子：11.6
JCR分区：Q1

基本信息

《医学研究评论》及时发表与医学研究相关的评论和观点性文章，广泛定义，作者对此做出了重大贡献。适当的主题包括但不限于重要疾病和病媒的潜在病理生理学;治疗各种疾病的治疗方法;治疗剂的分子靶的性质;促进治疗研究的重要新方法;基因组学和蛋白质组学;系列药物的构效关系;开发新的成像和诊断工具;药物代谢;药物递送;以及重要药物的化学、药理、药代动力学、药效学和临床特点。但也鼓励自愿捐款。在后一种情况下，为了避免重复工作，并确保主题和覆盖范围的适当性，要求潜在作者在开始写作之前与主编联系，并提供大纲（见下文）。
0198-6325SCIE/Scopus收录
11.6
点击查看最新影响趋势>
12.9
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CHEMISTRY, MEDICINAL
SCIE
Q1
1/72
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
11/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CHEMISTRY, MEDICINAL
SCIE
Q1
3/72
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
22/353
119
68
点击查看年发文量趋势图>
23%0约稿?周期不定-医学-药学
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
2.94%18.23%-
CiteScore：29.50
SJR：3.169
SNIP：3.113
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Pharmacology
Q1
3 / 321
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Drug Discovery
Q1
3 / 156
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Molecular Medicine
Q1
5 / 177

期刊高被引文献

Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21528
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21542
Recent clinical trends in Toll‐like receptor targeting therapeutics
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21553
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21572
Selective targeting of antiapoptotic BCL‐2 proteins in cancer
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21516
Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21596
Complex roles of the old drug aspirin in cancer chemoprevention and therapy
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21514
Phage therapy: Current status and perspectives
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21593
Antiaging effects of bioactive molecules isolated from plants and fungi
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21559
Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21511
Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21580
Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21628
Efflux pump inhibitors of clinically relevant multidrug resistant bacteria
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21591
Design and synthesis of glycomimetics: Recent advances
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21625
Death‐associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21518
Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21512
Drug delivery systems designed to overcome antimicrobial resistance
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21588
Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21510
Lipidic prodrug approach for improved oral drug delivery and therapy
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21533
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21513
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21562
Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21649
Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21551
Repurposing approved drugs on the pathway to novel therapies
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21627
Alternative oxidase inhibitors: Mitochondrion‐targeting as a strategy for new drugs against pathogenic parasites and fungi
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21560
Targeting MDM2 for novel molecular therapy: Beyond oncology
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21637
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domain
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21548
Orexin supplementation in narcolepsy treatment: A review
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21550
Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant Plasmodium falciparum
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21643
Therapeutic strategies for targeting telomerase in cancer
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21626
Progress in the application of CRISPR: From gene to base editing
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21537
Carbon monoxide: An emerging therapy for acute kidney injury
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21650
Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21538
Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21590
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21601
Norovirus antivirals: Where are we now?
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21545
Polyphenolic natural products and natural product–inspired steroidal mimics as aromatase inhibitors
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21536
Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21541
Challenges and approaches in the discovery of human immunodeficiency virus type‐1 non‐nucleoside reverse transcriptase inhibitors
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21544
Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21546
Bioactive peptides and proteins as alternative antiplatelet drugs
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21579
Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21646
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21645
The mitochondrial permeability transition pore in cell death: A promising drug binding bioarchitecture
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21635
Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21642
Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21648
Tissue engineering strategies combining molecular targets against inflammation and fibrosis, and umbilical cord blood stem cells to improve hampered muscle and skin regeneration following cleft repair
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21594
Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21566
Targeting virulence factors as an antimicrobial approach: Pigment inhibitors
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21621
Synthesis of histidine kinase inhibitors and their biological properties
来源期刊：Medicinal Research ReviewsDOI：10.1002/med.21651

相关文章

Medicinal Research Reviews：影响因子11.6，双1区TOP，药物研究领域综述期刊，年发文不足70篇，审稿慢，国人友好但录用难度大，无预警风险。
2025-09-11
Medicinal Research Reviews ：中科院1区，JCR分区为1区，平均录用比例为11%，非OA
2025-09-10
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
是
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
PHARMACOLOGY & PHARMACY 药学
1区
是
是